SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-23-000318
Filing Date
2023-01-30
Accepted
2023-01-30 06:37:48
Documents
1
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 zk2329093.html 3  
1 zk2329093.xml 3 4300
  Complete submission text file 0001178913-23-000318.txt   6523
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 34 YERUSHALAYIM RD. RAANANA L3 4350110
Business Address 34 YERUSHALAYIM RD. RAANANA L3 4350110 972(73)3989560
aMoon Growth Fund Limited Partnership (Reporting) CIK: 0001744099 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36138 | Film No.: 23565148

Mailing Address YERUSHALAYIM ROAD 34 BEIT GAMLA ENTRANCE B RA'ANANA L3 4350110
Business Address
Schindel Yair Chaim (Reporting) CIK: 0001823758 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36138 | Film No.: 23565147